A new trading day began on Tuesday, with X4 Pharmaceuticals Inc (NASDAQ: XFOR) stock price down -14.01% from the previous day of trading, before settling in for the closing price of $4.14. XFOR’s price has ranged from $2.67 to $33.90 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -82.72%. With a float of $3.86 million, this company’s outstanding shares have now reached $5.79 million.
The extent of productivity of a business whose workforce counts for 143 workers is very important to gauge. In terms of profitability, gross margin is 82.42%, operating margin of -27.28%, and the pretax margin is 47.58%.
X4 Pharmaceuticals Inc (XFOR) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of X4 Pharmaceuticals Inc is 33.34%, while institutional ownership is 29.32%. The most recent insider transaction that took place on May 16 ’25, was worth 2,561. In this transaction Chief Commercial Officer of this company bought 1,032 shares at a rate of $2.48, taking the stock ownership to the 25,337 shares. Before that another transaction happened on Nov 15 ’24, when Company’s Chief Commercial Officer bought 13,404 for $0.34, making the entire transaction worth $4,598. This insider now owns 129,173 shares in total.
X4 Pharmaceuticals Inc (XFOR) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -3.02 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -82.72% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 50.77% during the next five years compared to 47.41% growth over the previous five years of trading.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Trading Performance Indicators
Here are X4 Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.58. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.66.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.24, a number that is poised to hit -2.48 in the next quarter and is forecasted to reach -8.86 in one year’s time.
Technical Analysis of X4 Pharmaceuticals Inc (XFOR)
The latest stats from [X4 Pharmaceuticals Inc, XFOR] show that its last 5-days average volume of 0.57 million was superior to 0.15 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 65.12%. Additionally, its Average True Range was 0.46.
During the past 100 days, X4 Pharmaceuticals Inc’s (XFOR) raw stochastic average was set at 4.09%, which indicates a significant decrease from 48.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 138.35% in the past 14 days, which was higher than the 124.69% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.57, while its 200-day Moving Average is $13.14.
